July, 2023

Transire Bio receives CHF 10’000 and advances to the next stage of Venture Kick!

Venture Kick is a philanthropic initiative with a three-stage funding model initiated to financially support Swiss startups to kick-start their entrepreneurial journey. Moreover, Venture Kick provides media exposure, credibility, kickers camps, and access to a broad network of industry experts and investors to the selected projects.

Read the announcement at Startups developing AI-based nutritional tracking, decarbonized amonia production, a technology to uncover underground corrosion, restoration of soil health, and painless delivery of injectable drugs each win CHF 10,000 (venturekick.ch) and check our profile on their website Transire Bio – Venture Kick. Learn more about the Venture Kick at Venture Kick – CHF 150,000 to kick your startup.

Transire Bio receives a voucher for the Innosuisse Initial Coaching! The voucher can be used for coaching sessions with Innosuisse accredited coaches with expertise in biotech, medtech, financing, legal and other startup relevant topics. Innosuisse is the Swiss Innovation Agency with the goal to promote science-based innovations aligned with the economic and societal interests of Switzerland.

Learn more about Innosusse at https://www.innosuisse.ch/inno/en/home.html.

With the support of Innosuisse, we will further optimize our formulation and develop a zero-waste OctoPatch^®, which will help us meet our sustainability goals. For these tasks, the group of Drug Formulation and Delivery at ETH received the Innosuisse innovation grant worth CHF 305’624.00. Innosuisse is the Swiss Innovation Agency with the goal to promote science-based innovations aligned with the economic and societal interests of Switzerland.

Read the summary of the project at https://www.aramis.admin.ch/Texte/?ProjectID=53460. Learn more about Innosusse at https://www.innosuisse.ch/inno/en/home.html.